USPTO serial 97581907
Serial No. 97581907
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 12, 2023
- Examiner
- MAI, TINA HSIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 97581907?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrea M. Porterfield
Andrea M. Porterfield POLSINELLI PC900 W. 48TH PLACE, SUITE 900KANSAS CITY, MO 64112UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of dermatological, ophthalmic, respiratory, bacterial-based, urological, hormonal, gastrointestinal, cardiovascular, and psychiatric diseases and disorders; pharmaceutical preparations for the treatment of diabetes, migraines, and seizures; pharmaceutical preparations for use in pain management; transdermal patches for use in the treatment of nausea, vomiting; transdermal patches for the delivery of hormonal preparations; pharmaceutical preparations for inhalation for use in treatment of respiratory diseases and disorders and COPD; inhalers sold filled with aerosol inhalation preparations for the treatment of respiratory and neurological diseases and disorders; nasal and oral spray preparations for the treatment of bacterial-based, cardiovascular, hormonal, migraines, seizures, pain management, respiratory, neurological, and dermatological diseases and disorders; anti-infective preparations; antiviral preparations; antibiotics; antifungal preparations; anti-inflammatory preparations; cough treatment preparations; pharmaceutical preparations for use as a vehicle for compounding other pharmaceuticals | ACTIVE | — |
| 040 | Custom manufacture of pharmaceutical preparations for others | ACTIVE | — |
| 042 | Research and development in the fields of pharmaceuticals and medicine; research and development of new products for others; research and development of pharmaceutical preparations; design of pharmaceutical preparations; testing of pharmaceutical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 12, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 12, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 7, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 6, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 25, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 23, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 10, 2023 | IUAF | USE AMENDMENT FILED | — |
| Oct 10, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 19, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 25, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 25, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 5, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 22, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 22, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 22, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 22, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 10, 2022 | NWAP | NEW APPLICATION ENTERED | — |